Botulinum toxin injection for retrograde cricopharyngeal muscle dysfunction syndrome
Retrograde cricopharyngeal dysfunction (RCPD) syndrome renders patients unable to belch, causing disabling symptoms that impact quality of life. Injection of botulinum toxin into the cricopharyngeal muscle has been reported as a trial treatment for both therapeutic and diagnostic purposes. We descri...
Gespeichert in:
| Veröffentlicht in: | European annals of otorhinolaryngology, head and neck diseases head and neck diseases, 2024-12 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | European annals of otorhinolaryngology, head and neck diseases |
| container_volume | |
| creator | Thibault, C. Mailly, M. Debry, C. Schultz, P. Fath, L. |
| description | Retrograde cricopharyngeal dysfunction (RCPD) syndrome renders patients unable to belch, causing disabling symptoms that impact quality of life. Injection of botulinum toxin into the cricopharyngeal muscle has been reported as a trial treatment for both therapeutic and diagnostic purposes. We describe the injection technique, under general anesthesia using endoscopy or by transcutaneous injection with electromyographic control. |
| doi_str_mv | 10.1016/j.anorl.2024.11.010 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3147481640</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1879729624001662</els_id><sourcerecordid>3147481640</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1544-b35aca6ad3fd88d1c06059ed178ea5d8bc113e058bc5a9f878e92bfd7fbd69fb3</originalsourceid><addsrcrecordid>eNp9kE1LBDEMhosoKqu_QJA5etmx2c5He_Cg4hcIXhS8lU6bapeZdm1nxP33Vlc9mktC8r4JeQg5AloCheZ0WSofYl8u6KIqAUoKdIvsA2_FvGX0efu3XohmjxymtKQ5GOeCil2yx0RL87zaJ48XYZx656ehGMOH84XzS9SjC76wIRYRxxheojJY6Oh0WL2quPYvqPpimJLusTDrZCe_caS1NzEMeEB2rOoTHv7kGXm6vnq8vJ3fP9zcXZ7fzzXUVTXvWK20apRh1nBuQNOG1gINtBxVbXinARjSOhe1Epbntlh01rS2M42wHZuRk83eVQxvE6ZRDi5p7HvlMUxJMqjaikNT0SxlG6mOIaWIVq6iG_IzEqj8IiqX8puo_CIqAWQmml3HPwembkDz5_nllwVnGwHmN98dRpm0Q6_RuJgxShPcvwc-AXiMixM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3147481640</pqid></control><display><type>article</type><title>Botulinum toxin injection for retrograde cricopharyngeal muscle dysfunction syndrome</title><source>Elsevier ScienceDirect Journals</source><creator>Thibault, C. ; Mailly, M. ; Debry, C. ; Schultz, P. ; Fath, L.</creator><creatorcontrib>Thibault, C. ; Mailly, M. ; Debry, C. ; Schultz, P. ; Fath, L.</creatorcontrib><description>Retrograde cricopharyngeal dysfunction (RCPD) syndrome renders patients unable to belch, causing disabling symptoms that impact quality of life. Injection of botulinum toxin into the cricopharyngeal muscle has been reported as a trial treatment for both therapeutic and diagnostic purposes. We describe the injection technique, under general anesthesia using endoscopy or by transcutaneous injection with electromyographic control.</description><identifier>ISSN: 1879-7296</identifier><identifier>ISSN: 1879-730X</identifier><identifier>EISSN: 1879-730X</identifier><identifier>DOI: 10.1016/j.anorl.2024.11.010</identifier><identifier>PMID: 39701874</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Botulinum toxin ; Quality of life ; RCPD</subject><ispartof>European annals of otorhinolaryngology, head and neck diseases, 2024-12</ispartof><rights>2024 Elsevier Masson SAS</rights><rights>Copyright © 2024 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1544-b35aca6ad3fd88d1c06059ed178ea5d8bc113e058bc5a9f878e92bfd7fbd69fb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.anorl.2024.11.010$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39701874$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thibault, C.</creatorcontrib><creatorcontrib>Mailly, M.</creatorcontrib><creatorcontrib>Debry, C.</creatorcontrib><creatorcontrib>Schultz, P.</creatorcontrib><creatorcontrib>Fath, L.</creatorcontrib><title>Botulinum toxin injection for retrograde cricopharyngeal muscle dysfunction syndrome</title><title>European annals of otorhinolaryngology, head and neck diseases</title><addtitle>Eur Ann Otorhinolaryngol Head Neck Dis</addtitle><description>Retrograde cricopharyngeal dysfunction (RCPD) syndrome renders patients unable to belch, causing disabling symptoms that impact quality of life. Injection of botulinum toxin into the cricopharyngeal muscle has been reported as a trial treatment for both therapeutic and diagnostic purposes. We describe the injection technique, under general anesthesia using endoscopy or by transcutaneous injection with electromyographic control.</description><subject>Botulinum toxin</subject><subject>Quality of life</subject><subject>RCPD</subject><issn>1879-7296</issn><issn>1879-730X</issn><issn>1879-730X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LBDEMhosoKqu_QJA5etmx2c5He_Cg4hcIXhS8lU6bapeZdm1nxP33Vlc9mktC8r4JeQg5AloCheZ0WSofYl8u6KIqAUoKdIvsA2_FvGX0efu3XohmjxymtKQ5GOeCil2yx0RL87zaJ48XYZx656ehGMOH84XzS9SjC76wIRYRxxheojJY6Oh0WL2quPYvqPpimJLusTDrZCe_caS1NzEMeEB2rOoTHv7kGXm6vnq8vJ3fP9zcXZ7fzzXUVTXvWK20apRh1nBuQNOG1gINtBxVbXinARjSOhe1Epbntlh01rS2M42wHZuRk83eVQxvE6ZRDi5p7HvlMUxJMqjaikNT0SxlG6mOIaWIVq6iG_IzEqj8IiqX8puo_CIqAWQmml3HPwembkDz5_nllwVnGwHmN98dRpm0Q6_RuJgxShPcvwc-AXiMixM</recordid><startdate>20241218</startdate><enddate>20241218</enddate><creator>Thibault, C.</creator><creator>Mailly, M.</creator><creator>Debry, C.</creator><creator>Schultz, P.</creator><creator>Fath, L.</creator><general>Elsevier Masson SAS</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20241218</creationdate><title>Botulinum toxin injection for retrograde cricopharyngeal muscle dysfunction syndrome</title><author>Thibault, C. ; Mailly, M. ; Debry, C. ; Schultz, P. ; Fath, L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1544-b35aca6ad3fd88d1c06059ed178ea5d8bc113e058bc5a9f878e92bfd7fbd69fb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Botulinum toxin</topic><topic>Quality of life</topic><topic>RCPD</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thibault, C.</creatorcontrib><creatorcontrib>Mailly, M.</creatorcontrib><creatorcontrib>Debry, C.</creatorcontrib><creatorcontrib>Schultz, P.</creatorcontrib><creatorcontrib>Fath, L.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European annals of otorhinolaryngology, head and neck diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thibault, C.</au><au>Mailly, M.</au><au>Debry, C.</au><au>Schultz, P.</au><au>Fath, L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Botulinum toxin injection for retrograde cricopharyngeal muscle dysfunction syndrome</atitle><jtitle>European annals of otorhinolaryngology, head and neck diseases</jtitle><addtitle>Eur Ann Otorhinolaryngol Head Neck Dis</addtitle><date>2024-12-18</date><risdate>2024</risdate><issn>1879-7296</issn><issn>1879-730X</issn><eissn>1879-730X</eissn><abstract>Retrograde cricopharyngeal dysfunction (RCPD) syndrome renders patients unable to belch, causing disabling symptoms that impact quality of life. Injection of botulinum toxin into the cricopharyngeal muscle has been reported as a trial treatment for both therapeutic and diagnostic purposes. We describe the injection technique, under general anesthesia using endoscopy or by transcutaneous injection with electromyographic control.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>39701874</pmid><doi>10.1016/j.anorl.2024.11.010</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1879-7296 |
| ispartof | European annals of otorhinolaryngology, head and neck diseases, 2024-12 |
| issn | 1879-7296 1879-730X 1879-730X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_3147481640 |
| source | Elsevier ScienceDirect Journals |
| subjects | Botulinum toxin Quality of life RCPD |
| title | Botulinum toxin injection for retrograde cricopharyngeal muscle dysfunction syndrome |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T17%3A34%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Botulinum%20toxin%20injection%20for%20retrograde%20cricopharyngeal%20muscle%20dysfunction%20syndrome&rft.jtitle=European%20annals%20of%20otorhinolaryngology,%20head%20and%20neck%20diseases&rft.au=Thibault,%20C.&rft.date=2024-12-18&rft.issn=1879-7296&rft.eissn=1879-730X&rft_id=info:doi/10.1016/j.anorl.2024.11.010&rft_dat=%3Cproquest_cross%3E3147481640%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3147481640&rft_id=info:pmid/39701874&rft_els_id=S1879729624001662&rfr_iscdi=true |